BIO recommends improvements to FDA’s clinical trial diversity guidance
On April 13, the U.S. Food and Drug Administration (FDA) released new draft guidance for industry on “creating strategies to recruit additional participants from underrepresented […]
BIO recommends improvements to FDA’s clinical trial diversity guidance Read More »